Argenx to present at upcoming investor conferences

November 1, 2023 amsterdam, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in several upcoming investor conferences in november:

ARGX Ratings Summary

ARGX Quant Ranking